Sartorius grows operations in France

By Monish Makena, The Science Advisory Board contributing writer

November 30, 2021 -- Sartorius is expanding its capacities for production, innovation, and storage in France by investing 100 million euros ($117 million) between 2021 and 2025.

At the end of 2020, Sartorius employed almost 1,100 people on permanent contracts across four different sites in France. The expansion will create up to 400 new jobs via permanent employment contracts in the next four years.

As part of the expansion, Sartorius will create an additional 4,000 square meters of cleanroom space. In addition, the company plans to deploy new R&D laboratories (2,000 square meters), upgrade company logistics platforms, build warehouse facilities and storage depots, and digitalize and automate equipment.

Waters, Sartorius to partner on mass spectrometry data
Waters and Sartorius announced that they will partner to provide direct access to mass spectrometry data to improve the accuracy of biopharmaceutical...
Sartorius to open new plant in Mich.
Life science research firm Sartorius plans to expand its North American business by building a new 130,000-sq-ft plant in Ann Arbor, MI. The new facility...
McMaster, Sartorius partner on improving biomanufacturing
Sartorius Stedim Biotech and McMaster University, which is located in Hamilton, Ontario, Canada, plan to collaborate on an effort to improve advanced...
Sartorius buys viral vector media company Xell for $59M
Sartorius Stedim Biotech has acquired cell culture company Xell, which is headquartered in Bielefeld, Germany.
Sartorius acquires majority stake in CellGenix
Life science company Sartorius has acquired a 51% stake in reagent manufacturer CellGenix through its subsidiary Sartorius Stedim Biotech.

Copyright © 2021

Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter